Abnormalities in UBQLN2 expression and function are linked to numerous neurodegenerative diseases, including Alzheimer’s, Parkinson’s, amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD)5–10. Here, UBQLN2 is linked to amyotrophic lateral sclerosis.